Vsquared Ventures — 2025 Investments
4 investments dated 2025 · listed companies and verified rows first · show all
Atrandi makes Flux, a device that isolates thousands to hundreds of thousands of individual cells simultaneously into semi-permeable capsules for downstream genomic and microbial analysis.
AI & Machine LearningBiotechDeep TechHardwareVilnius, LT
Co-investorsGRIDS CapitalLux CapitalMetaplanetPractica Capital
Belfort develops hardware and algorithms to accelerate encrypted computation, including Fully Homomorphic Encryption, so sensitive data can be processed without being decrypted.
CybersecurityDeep TechHardware
Michiel Van Beirendonck(Principal Architect / Co-founder)inLaurens De Poorter(Co-founder)in
Co-investorsSyndicate OneAnagram VenturesCredibly NeutralInovia Capital
Hedera Dx develops in-house, NGS-based liquid biopsy tests and clinicogenomic data solutions for decentralized oncology care, partnering with laboratories and clinicians to support cancer diagnosis and personalized therapy selection.
AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices
Tommi Lehtonen(CEO, Co-founder)inDamien Lapray(CCO, Co-founder, PhD)inChristian Meisel(CMO, Co-founder, MD PhD)inFrances Rhodius(CFO)
Co-investorsAmino CollectiveBootstrap EuropeHelsana HealthInvest AGInventureInventureTesi (Finnish Industry Investment Ltd)
Safe Intelligence provides a software platform, tooling, and services that use formal verification, testing, and robust learning to validate and harden machine learning models such as neural networks and tree ensembles.
AI & Machine LearningCybersecurityDeep TechDeveloper Tools
Steven Willmott(CEO)inAlessio Lomuscio(CTO)in
Co-investorsAmadeus Capital PartnersOTB Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





















